当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
TRUMENBA, Meningococcal Group B Vaccine
申请企业
Wyeth Pharmaceuticals LLC
药品名称
TRUMENBA, Meningococcal Group B Vaccine
承诺描述
To conduct a study to assess safety, tolerability, and immunogenicity of Trumenba administered on a 0-, 6-month schedule in healthy subjects aged =10 to less than 26 years
报告接收日期
2020/12/18 0:00:00